These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
295 related items for PubMed ID: 24576072
21. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases. Yeh MM, Larson AM, Campbell JS, Fausto N, Rulyak SJ, Swanson PE. Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450 [Abstract] [Full Text] [Related]
22. Epithelial-mesenchymal transition-related genes are linked to aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation. Iwahashi S, Shimada M, Utsunomiya T, Imura S, Morine Y, Ikemoto T, Takasu C, Saito Y, Yamada S. Cancer Lett; 2016 May 28; 375(1):47-50. PubMed ID: 26940140 [Abstract] [Full Text] [Related]
23. MicroRNA-155 attenuates activation of hepatic stellate cell by simultaneously preventing EMT process and ERK1 signalling pathway. Dai W, Zhao J, Tang N, Zeng X, Wu K, Ye C, Shi J, Lu C, Ning B, Zhang J, Lin Y. Liver Int; 2015 Apr 28; 35(4):1234-43. PubMed ID: 25142507 [Abstract] [Full Text] [Related]
24. Hepatitis B virus regulates apoptosis and tumorigenesis through the microRNA-15a-Smad7-transforming growth factor beta pathway. Liu N, Jiao T, Huang Y, Liu W, Li Z, Ye X. J Virol; 2015 Mar 28; 89(5):2739-49. PubMed ID: 25540364 [Abstract] [Full Text] [Related]
25. The microRNA-200 family--a potential diagnostic marker in hepatocellular carcinoma? Dhayat SA, Mardin WA, Köhler G, Bahde R, Vowinkel T, Wolters H, Senninger N, Haier J, Mees ST. J Surg Oncol; 2014 Sep 28; 110(4):430-8. PubMed ID: 24895326 [Abstract] [Full Text] [Related]
26. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus. Yeh TS, Wang F, Chen TC, Yeh CN, Yu MC, Jan YY, Chen MF. Ann Surg; 2014 Feb 28; 259(2):346-54. PubMed ID: 24135722 [Abstract] [Full Text] [Related]
27. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. Ning BF, Ding J, Yin C, Zhong W, Wu K, Zeng X, Yang W, Chen YX, Zhang JP, Zhang X, Wang HY, Xie WF. Cancer Res; 2010 Oct 01; 70(19):7640-51. PubMed ID: 20876809 [Abstract] [Full Text] [Related]
28. Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers. Bedossa P, Peltier E, Terris B, Franco D, Poynard T. Hepatology; 1995 Mar 01; 21(3):760-6. PubMed ID: 7875675 [Abstract] [Full Text] [Related]
29. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin JS. Oncogene; 2012 Jul 12; 31(28):3357-69. PubMed ID: 22056881 [Abstract] [Full Text] [Related]
30. Functional analysis of miR-181a and Fas involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis. Zou C, Chen J, Chen K, Wang S, Cao Y, Zhang J, Sheng Y, Huang A, Tang H. Exp Cell Res; 2015 Feb 15; 331(2):352-61. PubMed ID: 25449696 [Abstract] [Full Text] [Related]
31. Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition. Barker TH, Dysart MM, Brown AC, Douglas AM, Fiore VF, Russell AG, HEI Health Review Committee. Res Rep Health Eff Inst; 2014 Nov 15; (182):3-41. PubMed ID: 25669020 [Abstract] [Full Text] [Related]
32. Interaction of transforming growth factor-β-Smads/microRNA-362-3p/CD82 mediated by M2 macrophages promotes the process of epithelial-mesenchymal transition in hepatocellular carcinoma cells. Zhang Q, Huang F, Yao Y, Wang J, Wei J, Wu Q, Xiang S, Xu L. Cancer Sci; 2019 Aug 15; 110(8):2507-2519. PubMed ID: 31215741 [Abstract] [Full Text] [Related]
33. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy. Wang JY, Gao YB, Zhang N, Zou DW, Wang P, Zhu ZY, Li JY, Zhou SN, Wang SC, Wang YY, Yang JK. Mol Cell Endocrinol; 2014 Jul 05; 392(1-2):163-72. PubMed ID: 24887517 [Abstract] [Full Text] [Related]
34. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1. Yang L, Inokuchi S, Roh YS, Song J, Loomba R, Park EJ, Seki E. Gastroenterology; 2013 May 05; 144(5):1042-1054.e4. PubMed ID: 23391818 [Abstract] [Full Text] [Related]
35. Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition. Tanahashi T, Osada S, Yamada A, Kato J, Yawata K, Mori R, Imai H, Sasaki Y, Saito S, Tanaka Y, Nonaka K, Yoshida K. Int J Oncol; 2013 Feb 05; 42(2):556-64. PubMed ID: 23229794 [Abstract] [Full Text] [Related]
36. Epithelial-Mesenchymal Transition (EMT) Induced by TGF-β in Hepatocellular Carcinoma Cells Reprograms Lipid Metabolism. Soukupova J, Malfettone A, Bertran E, Hernández-Alvarez MI, Peñuelas-Haro I, Dituri F, Giannelli G, Zorzano A, Fabregat I. Int J Mol Sci; 2021 May 24; 22(11):. PubMed ID: 34073989 [Abstract] [Full Text] [Related]
37. Suppression of epithelial-mesenchymal transition in hepatocellular carcinoma cells by Krüppel-like factor 4. Li Q, Song W, Wang W, Yao S, Tian C, Cai X, Wang L. Oncotarget; 2016 May 17; 7(20):29749-60. PubMed ID: 27102441 [Abstract] [Full Text] [Related]
38. DNAJC6 promotes hepatocellular carcinoma progression through induction of epithelial-mesenchymal transition. Yang T, Li XN, Li XG, Li M, Gao PZ. Biochem Biophys Res Commun; 2014 Dec 12; 455(3-4):298-304. PubMed ID: 25446072 [Abstract] [Full Text] [Related]
39. miR-181a promotes osteoblastic differentiation through repression of TGF-β signaling molecules. Bhushan R, Grünhagen J, Becker J, Robinson PN, Ott CE, Knaus P. Int J Biochem Cell Biol; 2013 Mar 12; 45(3):696-705. PubMed ID: 23262291 [Abstract] [Full Text] [Related]
40. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression. Li CH, Xu F, Chow S, Feng L, Yin D, Ng TB, Chen Y. Eur J Cancer; 2014 Oct 12; 50(15):2560-9. PubMed ID: 25087183 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]